Stock listing
Neurothera Labs Inc.
Selected listing: C0A · FWB · EUR · DE
Neurothera Labs Inc. (Frankfurt:C0A), Finance. Latest release Sep 23, 2026: NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration…
- Ticker
- Frankfurt:C0A
- Asset type
- Stock
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- Frankfurt
- Currency
- EUR
About Neurothera Labs Inc.
The company focuses on developing innovative solutions in the healthcare sector. Neurothera Labs aims to address unmet medical needs through its research and product offerings.
Latest news from Neurothera Labs Inc.
NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations
September 23, 2026
SciSparc Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation for Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
September 2, 2026
NeuroThera Labs Achieves Significant Enrollment Momentum in SCI210 Autism Clinical Trial
August 31, 2026
Neurothera Labs Inc. Announces Share Consolidation
August 28, 2026
NeuroThera Labs Engages Dr. Reuter Investor Relations
August 27, 2026
Research Neurothera Labs Inc.
Neurothera Labs Inc. company profile
View the public company page for Neurothera Labs Inc. on 6ix.
Neurothera Labs Inc. news
Read company news and market updates connected to Neurothera Labs Inc..
Neurothera Labs Inc. investor events
Find investor webinars, events, and replay context for Neurothera Labs Inc..